Oxford Instruments NanoScience Contributes Cutting-Edge Technology to OQC’s New York Quantum-AI Data Centre
Oxford, UK, November 05 2025 -- Oxford Instruments NanoScience today announced that one of its leading Cryofree dilution refrigerators, the ProteoxLX, is forming part of Oxford Quantum Circuits (OQC) newly launched Quantum-AI Data Centre in New York. As the industry’s first facility designed specifically to co-locate quantum computing and classical AI infrastructure at scale, the centre will leverage ProteoxLX’s advanced cryogenic performance to support OQC’s next-generation quantum processors, accelerating the development and deployment of quantum-enabled AI applications.
The announcement follows OQC’s unveiling last month of its New York-based Quantum-AI Data Centre, powered by NVIDIA CPU/GPU Superchips, which marks a significant step toward scalable, real-world quantum computing applications. As part of OQC’s logical-era quantum computer, OQC GENESIS, the ProteoxLX provides the ultra-low temperature environment and cooling power required to support the device, which features 16 logical qubits and is capable of delivering over 1,000 quantum operations.
The system will enable breakthroughs across finance, security and data-driven industries, from accelerating financial modelling and mission-critical optimisation, to powering next-generation AI and quantum machine learning.
The contribution underscores Oxford Instruments NanoScience’s growing role in the global quantum ecosystem. With data centre installations across Europe, North America, and Asia, OQC, in collaboration with Oxford Instruments NanoScience, is contributing to a globally distributed quantum computing infrastructure. The companies are accelerating the practical deployment of quantum computing solutions, enabling applications across superconducting qubits for major industries such as the pharmaceutical sector.
“We’re proud to support OQC in building the infrastructure that will define the next generation of computing, and it is a privilege to collaborate with our longstanding partner on this project,” said Matthew Martin, Managing Director, Oxford Instruments NanoScience. “Our ProteoxLX is designed to allow users to scale, enabling them to maximise qubit counts with a large sample space and capacity for coaxial lines, so we’re excited to see how OQC will harness this platform to accelerate breakthroughs in real-world application performance.”
Oxford Instruments NanoScience’s ProteoxLX, designed specifically for quantum computing scale-up and optimised to provide long-term reliability, stability and ease of use, provides the ultra-low temperature environment that qubits need to function. The system's market-leading modular, upgradable platform, which contains cross-compatible magnet systems, enables extensive user flexibility, allowing OQC to integrate increasingly complex superconducting qubit devices.
Simon Phillips, CTO, OQC, commented: “Oxford Instruments NanoScience’s contribution supports the centre’s goal of creating a hybrid quantum-classical computing capability, without modifying the data centre environment or generating the need for additional cooling.”


